Aquila Solutions, LLC
@aquila_solutions_llc
Warner Robins, Georgiahttp://aquilasolutions.us Biotechnology ResearchOverview
About Aquila Solutions, LLC
Aquila is a Regulatory Publishing Services Company specializing in the publishing needs of Pharmaceuticals and Biologics companies. Our goal is ‘First Pass’ approval of your application while assisting you to develop your long term lifecycle management needs. Most submissions are completed within 24 hours. Contact us for the fastest service available!
We provide every service necessary to successfully submit your application including eCTD (INDs, (A)NDAs, BLAs, MAAs CTAs and others), SPL, ClinicalTrials.gov submission, SAS Data Package review and other services you may need to publish your application and win approval.
Aquila also believes in supporting our clients past the current sequence or application. We support our clients through the full lifecycle of their products and assist as needed to support their publishing needs at the lowest cost possible. This often includes assisting our clients develop their internal RegOps systems. We help clients internalize systems where appropriate, outsource where necessary and always provide the most cost effective solution for your unique situation.
Sincerely,
Josh Boutwell, MBA RAC
CEO and Founder
We provide every service necessary to successfully submit your application including eCTD (INDs, (A)NDAs, BLAs, MAAs CTAs and others), SPL, ClinicalTrials.gov submission, SAS Data Package review and other services you may need to publish your application and win approval.
Aquila also believes in supporting our clients past the current sequence or application. We support our clients through the full lifecycle of their products and assist as needed to support their publishing needs at the lowest cost possible. This often includes assisting our clients develop their internal RegOps systems. We help clients internalize systems where appropriate, outsource where necessary and always provide the most cost effective solution for your unique situation.
Sincerely,
Josh Boutwell, MBA RAC
CEO and Founder